These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18008169)

  • 1. Virtual screening applications: a study of ligand-based methods and different structure representations in four different scenarios.
    Hristozov DP; Oprea TI; Gasteiger J
    J Comput Aided Mol Des; 2007; 21(10-11):617-40. PubMed ID: 18008169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-based virtual screening by novelty detection with self-organizing maps.
    Hristozov D; Oprea TI; Gasteiger J
    J Chem Inf Model; 2007; 47(6):2044-62. PubMed ID: 17854167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SABRE: ligand/structure-based virtual screening approach using consensus molecular-shape pattern recognition.
    Wei NN; Hamza A
    J Chem Inf Model; 2014 Jan; 54(1):338-46. PubMed ID: 24328054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trainable structure-activity relationship model for virtual screening of CYP3A4 inhibition.
    Didziapetris R; Dapkunas J; Sazonovas A; Japertas P
    J Comput Aided Mol Des; 2010 Nov; 24(11):891-906. PubMed ID: 20814717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Similarity search profiles as a diagnostic tool for the analysis of virtual screening calculations.
    Xue L; Godden JW; Stahura FL; Bajorath J
    J Chem Inf Comput Sci; 2004; 44(4):1275-81. PubMed ID: 15272835
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Performance of machine learning methods for ligand-based virtual screening.
    Plewczynski D; Spieser SA; Koch U
    Comb Chem High Throughput Screen; 2009 May; 12(4):358-68. PubMed ID: 19442065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Virtual screening data fusion using both structure- and ligand-based methods.
    Svensson F; Karlén A; Sköld C
    J Chem Inf Model; 2012 Jan; 52(1):225-32. PubMed ID: 22148635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effectiveness of graph-based and fingerprint-based similarity measures for virtual screening of 2D chemical structure databases.
    Raymond JW; Willett P
    J Comput Aided Mol Des; 2002 Jan; 16(1):59-71. PubMed ID: 12197666
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel 2D fingerprints for ligand-based virtual screening.
    Ewing T; Baber JC; Feher M
    J Chem Inf Model; 2006; 46(6):2423-31. PubMed ID: 17125184
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Integrating virtual screening in lead discovery.
    Oprea TI; Matter H
    Curr Opin Chem Biol; 2004 Aug; 8(4):349-58. PubMed ID: 15288243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel technologies for virtual screening.
    Lengauer T; Lemmen C; Rarey M; Zimmermann M
    Drug Discov Today; 2004 Jan; 9(1):27-34. PubMed ID: 14761803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Consideration of molecular weight during compound selection in virtual target-based database screening.
    Pan Y; Huang N; Cho S; MacKerell AD
    J Chem Inf Comput Sci; 2003; 43(1):267-72. PubMed ID: 12546562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toward fully automated high performance computing drug discovery: a massively parallel virtual screening pipeline for docking and molecular mechanics/generalized Born surface area rescoring to improve enrichment.
    Zhang X; Wong SE; Lightstone FC
    J Chem Inf Model; 2014 Jan; 54(1):324-37. PubMed ID: 24358939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LigMatch: a multiple structure-based ligand matching method for 3D virtual screening.
    Kinnings SL; Jackson RM
    J Chem Inf Model; 2009 Sep; 49(9):2056-66. PubMed ID: 19685924
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High-throughput structure-based pharmacophore modelling as a basis for successful parallel virtual screening.
    Steindl TM; Schuster D; Wolber G; Laggner C; Langer T
    J Comput Aided Mol Des; 2006 Dec; 20(12):703-15. PubMed ID: 17009092
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bayesian screening for active compounds in high-dimensional chemical spaces combining property descriptors and molecular fingerprints.
    Vogt M; Bajorath J
    Chem Biol Drug Des; 2008 Jan; 71(1):8-14. PubMed ID: 18069988
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ranking targets in structure-based virtual screening of three-dimensional protein libraries: methods and problems.
    Kellenberger E; Foata N; Rognan D
    J Chem Inf Model; 2008 May; 48(5):1014-25. PubMed ID: 18412328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spherical harmonics coefficients for ligand-based virtual screening of cyclooxygenase inhibitors.
    Wang Q; Birod K; Angioni C; Grösch S; Geppert T; Schneider P; Rupp M; Schneider G
    PLoS One; 2011; 6(7):e21554. PubMed ID: 21818259
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of topological descriptors for similarity-based virtual screening using multiple bioactive reference structures.
    Hert J; Willett P; Wilton DJ; Acklin P; Azzaoui K; Jacoby E; Schuffenhauer A
    Org Biomol Chem; 2004 Nov; 2(22):3256-66. PubMed ID: 15534703
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Virtual drug screen schema based on multiview similarity integration and ranking aggregation.
    Kang H; Sheng Z; Zhu R; Huang Q; Liu Q; Cao Z
    J Chem Inf Model; 2012 Mar; 52(3):834-43. PubMed ID: 22332590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.